Bridge Funding Grant Program in the Biomedical/Health Sciences Guidelines

Eligibility:

• Only full-time faculty at Touro University in New York, California, Nevada, Illinois, Berlin, and at New York Medical College are eligible for funding through this program.
• Applicants must have submitted a competitive, continuation / renewal grant application and received a critique that forecasts a reasonable expectation of future funding. In the case of funding sources that do not provide critiques, equivalent documentation from the sponsor should be provided.
• The Principal Investigator (PI) must have an active research program with demonstrable evidence of recent productivity (e.g., extramural support and publications within the past two years).
• PI must have exhausted all other forms of internal (e.g., start-up) or external funds available for support of the specific project or must demonstrate that such funds will be exhausted prior to the start date of a Bridge Funding grant.  Ideally, 90-95% of direct funding should have been expended during the period of the full period of prior funding.

Submission and Review Process:

• Letters of Intent are due: May 1, 2024
• This is a mandatory requirement going forward.
• The letter of intent must include the title of the proposed submission and specify all investigators and their affiliations and positions
• Applications for the spring competition are due on May 14, 2024.
• Applications must include the unsuccessful renewal application score (if available) and a copy of the critique/summary statement or some written indication of funding viability for the proposal.
• Proposed studies must specifically and carefully address the issues raised by the external review process. If applicants plan to seek continued funding from a different agency or program, they must justify the switch in sponsors and program and explain why a future proposal to the new sponsor ought to be considered potentially competitive. Provide a timeline for proposal submission.
• Applications will be reviewed by an internal review panel comprised of investigators who have active research programs and/or grant review experience at the national level (e.g., NIH or AHA). Composition of the review panel may vary for each submission deadline to insure appropriate content expertise.
• All proposals will be scored using NIH criteria modified to fit the purpose of this program.  A short written review will be provided to applicants.

Funding:

• Awards will be made for up to $50,000 for a twelve-month period. Awards for the fall competition are anticipated to start on or about June 2024.
• Proposals that are not funded on first submission may be revised and re-submitted at a subsequent deadline; however, such proposals must also specifically and carefully address the issues raised by the initial Bridge Funding Grant review.
• Budget direct costs may support scientific personnel, supplies, and services.  However, salary support for the PI is not permitted.  With very strong justification, equipment and/or travel costs necessary to conduct the research may be requested.

Questions:

Questions about the Bridge Funding Grant Program may be addressed to NYMC-OVPResearch@nymc.edu.